妊娠早期非酒精性脂肪性肝病与后续妊娠期糖尿病发生的关系
这项多中心前瞻性队列研究纳入608名单胎韩国孕妇,在孕10-14周用超声、脂肪肝指数和肝脂肪变指数评估NAFLD,24-28周两步法筛查GDM。NAFLD患病率18.4%,GDM发生率5.9%;NAFLD是GDM的独立危险因素,且与脂肪变严重程度正相关,脂联素可能有助于预测GDM。
要点
- 孕早期NAFLD是GDM的独立危险因素,风险随脂肪变严重程度增加。
- 纠正代谢危险因素(含胰岛素抵抗)后,NAFLD与GDM的关联仍显著。
- 脂联素和硒蛋白P与NAFLD严重程度及GDM风险相关。
核心结论
- 孕早期NAFLD是GDM的独立危险因素。
- 脂联素可能是预测孕妇GDM的有用生物标志物。
研究设计与样本
- 多中心前瞻性队列研究,纳入单胎韩国孕妇,最终分析608名。
- 孕10-14周用肝脏超声、脂肪肝指数和肝脂肪变指数评估NAFLD,并测血浆脂联素和硒蛋白P。
- 孕24-28周用两步法筛查GDM。
主要发现
- NAFLD患病率为18.4%(112/608),GDM发生率为5.9%(36/608)。
- 发生GDM者影像学脂肪变比例更高(55.6% vs 16.1%;p < 0.001)。
- 发生GDM者脂肪肝指数更高(40.0 vs 10.7;p < 0.001),肝脂肪变指数更高(35.5 vs 29.0;p < 0.001)。
- NAFLD者GDM风险显著增加,且与脂肪变严重程度正相关;校正代谢危险因素(含胰岛素抵抗)后关联仍显著。
- 母体血浆脂联素和硒蛋白P水平与NAFLD严重程度及GDM风险相关。
临床怎么用
- 孕早期可考虑用超声及脂肪肝指数、肝脂肪变指数识别NAFLD孕妇,以评估后续GDM风险。
- 对孕早期NAFLD孕妇应加强GDM筛查与代谢风险管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Although there is substantial evidence that non-alcoholic fatty liver disease (NAFLD) is associated with impaired glucose homeostasis, the clinical significance of NAFLD in pregnant women has not been well determined. This study investigates the relationship between NAFLD in the first trimester and the subsequent development of gestational diabetes mellitus (GDM). METHODS: A multicentre, prospective cohort study was conducted in which singleton pregnant Korean women were assessed for NAFLD at 10-14 weeks using liver ultrasound, fatty liver index (FLI) and hepatic steatosis index (HSI). Maternal plasma adiponectin and selenoprotein P concentrations were measured. Participants were screened for GDM using the two-step approach at 24-28 weeks. RESULTS: Six hundred and eight women were included in the final analysis. The prevalence of NAFLD was 18.4% (112/608) and 5.9% (36/608) developed GDM. Participants who developed GDM had a higher prevalence of radiological steatosis (55.6% vs 16.1%; p < 0.001) and higher FLI (40.0 vs 10.7; p < 0.001) and HSI (35.5 vs 29.0; p < 0.001). The risk of developing GDM was significantly increased in participants with NAFLD and was positively correlated with the severity of steatosis. This relationship between NAFLD and GDM remained significant after adjustment for metabolic risk factors, including measures of insulin resistance. Maternal plasma adiponectin and selenoprotein P levels were also correlated with both NAFLD severity and the risk of developing GDM. CONCLUSIONS/INTERPRETATION: NAFLD in early pregnancy is an independent risk factor for GDM. Adiponectin may be a useful biomarker for predicting GDM in pregnant women.
引用
- Lee SM, Kwak SH, Koo JN, et al. Non-alcoholic fatty liver disease in the first trimester and subsequent development of gestational diabetes mellitus. Diabetologia. 2018. PMID: 30470912. doi:10.1007/s00125-018-4779-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。